Search our Database of Scientific Publications and Authors

I’m looking for a

    179 results match your criteria Thyroid Dysfunction Induced by Amiodarone Therapy

    1 OF 4

    [Amiodarone-induced thyrotoxicosis].
    G Ital Cardiol (Rome) 2017 Mar;18(3):219-229
    Unità di Endocrinologia, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi, Pisa.
    Amiodarone-induced thyroid dysfunction occurs in about 15-20% of patients under amiodarone therapy. Amiodarone-induced hypothyroidism (AIH) can develop in patients with an apparently normal thyroid gland or in those with an underlying chronic autoimmune thyroiditis. On a clinical ground, AIH is not challenging and can be easily treated with L-thyroxine therapy. Read More

    Risk factors for amiodarone-induced thyroid dysfunction in Japan.
    J Arrhythm 2016 Dec 5;32(6):474-480. Epub 2016 May 5.
    Division of Clinical Drug Informatics, School of Pharmacy, Kinki University, 3-4-1, Kowakae, Higashiosaka, Osaka 577-0818, Japan.
    Background: Amiodarone is associated with a number of significant adverse effects, including elevated transaminase levels, pulmonary fibrosis, arrhythmia, and thyroid dysfunction. Although thyroid dysfunction is considered to be a common and potentially serious adverse effect of amiodarone therapy, the exact pathogenesis remains unknown because of its complex manifestations. Therefore, the prevalence of, and risk factors for, amiodarone-induced thyroid dysfunction in Japanese patients were investigated in the present study. Read More

    Adherence to guidelines in monitoring amiodarone-induced thyroid dysfunction.
    J Eval Clin Pract 2017 Feb 12;23(1):108-113. Epub 2016 Aug 12.
    Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
    Rationale, Aims And Objectives: Baseline thyroid function testing and regular follow-up of thyroid function under amiodarone usage was recommended by guidelines. Little is known about the status of amiodarone monitoring in real-world clinical care in Taiwan. The objective was to determine the rate of thyroid monitoring and to assess the clinical and physicians' characteristics associated with adequate monitoring in a tertiary referral centre for arrhythmia. Read More

    Safety and efficacy of early radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation complicated with amiodarone-induced thyrotoxicosis.
    Cardiol J 2016 14;23(4):416-21. Epub 2016 Jun 14.
    Department of Cardiology, The Affiliated Hospital of Qingdao Univer sity, Qingdao, China.
    Background: Amiodarone is an antiarrhythmic drug that is frequently used to control atrial fibrillation (AF). Many patients with AF are afraid of the risk of ablation and take amiodar-one, some patients develop amiodarone-induced thyrotoxicosis (AIT). The purpose of the study was to investigate the safety and efficacy of early radiofrequency catheter ablation in patients with paroxysmal AF complicated with AIT. Read More

    [Iodine excess induced thyroid dysfunction].
    Rev Med Suisse 2016 Apr;12(515):804-9
    The principle sources of iodine overload, amiodarone and radiologic contrast media, are frequently used in modern medicine. The thyroid gland exerts a protective effect against iodine excess by suppressing iodine internalization into the thyrocyte and iodine organification, the Wolff-Chaikoff effect. Insufficiency of this effect or lack of escape from it leads to hypo- or hyperthyroidism respectively. Read More

    Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases.
    Ther Clin Risk Manag 2016 4;12:505-13. Epub 2016 Apr 4.
    Department of Endocrinology, Metabolism and Internal Medicine, Poznan, Poland.
    Aim: This study aims to explore and compare the efficacy of radioiodine treatment (RIT) in hyperthyroid and euthyroid patients who have been treated with amiodarone (AM) in the past or are currently undergoing AM treatment. Clinical observation of a group of patients with amiodarone-induced hypothyroidism during a 12-month follow-up period was used for comparison.

    Design: This was a observational, two-centered study. Read More

    SERIAL CHANGES OF LIVER FUNCTION TESTS BEFORE AND DURING METHIMAZOLE TREATMENT IN THYROTOXIC PATIENTS.
    Endocr Pract 2016 Aug 4;22(8):974-9. Epub 2016 Apr 4.
    Objective: Overt hyperthyroidism and methimazole (MMI) treatment are frequently associated with abnormal liver function tests (LFTs). We describe the serial changes of LFTs in MMI-treated hyperthyroid patients.

    Methods: We retrospectively analyzed all 77 patients presenting with newly diagnosed overt hyperthyroidism (59 Graves diseases, 11 toxic nodular goiters, 4 toxic adenomas, 3 amiodarone-induced thyrotoxicosis) between 2012 and 2014. Read More

    Hyperthyroidism.
    Lancet 2016 Aug 30;388(10047):906-18. Epub 2016 Mar 30.
    Section of Endocrinology, Diabetes and Nutrition, Boston University School of Medicine, Boston, MA, USA. Electronic address:
    Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis refers to the clinical syndrome of excess circulating thyroid hormones, irrespective of the source. The most common cause of hyperthyroidism is Graves' disease, followed by toxic nodular goitre. Other important causes of thyrotoxicosis include thyroiditis, iodine-induced and drug-induced thyroid dysfunction, and factitious ingestion of excess thyroid hormones. Read More

    The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism.
    Pharmacol Rep 2016 Apr 15;68(2):490-4. Epub 2015 Dec 15.
    Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland.
    Background: Chronic metformin treatment was found to reduce elevated thyrotropin levels. Amiodarone treatment is associated with a range of effects in thyroid function from mild derangements to overt thyroid dysfunction. No previous study has investigated the effect of metformin on hypothalamic-pituitary-thyroid axis activity in patients with amiodarone-induced hypothyroidism. Read More

    [Clinical procedure in amiodarone-induced thyroid dysfunction].
    Pol Merkur Lekarski 2016 Jan;40(235):46-52
    Medical University of Lodz. Poland: Department of Electrocardiology, Chair of Cardiology and Cardiac Surgery.
    Amiodarone is an antiarrhythmic drug frequently used in everyday clinical practice. Its mechanism of action involves the interaction with many receptors, including those in the cardiac conduction system. Amiodarone usefulness is protect in the treatment of a variety of tachyarrhythmias, both benign and life-threatening. Read More

    Thyroid Disease and the Heart.
    Curr Probl Cardiol 2016 Feb 23;41(2):65-92. Epub 2015 Apr 23.
    Thyroid hormones have an intimate relationship with cardiac function. Some of the most significant clinical signs and symptoms of thyroid disease are the cardiac manifestations. In both hypothyroidism and hyperthyroidism, the characteristic physiological effects of thyroid hormone can be understood from the actions at the molecular and cellular level. Read More

    [AMIODARONE AND THE THYROID FUNCTION].
    Lijec Vjesn 2015 May-Jun;137(5-6):181-8
    Amiodarone is a benzofuran derivative that contains up to 40% of iodine. Amiodarone is used for treatment and prevention of life threatening supraventricular and ventricular tachyarrhythmias. The effects on thyroid gland vary from abnormalities in thyroid function tests to overt amiodarone induced hypothyroidism (AIH) and thyrotoxicosis (AIT). Read More

    [Clinical course and treatment of ectopic atrial tachycardia in 144 children].
    Zhonghua Er Ke Za Zhi 2015 Mar;53(3):214-9
    Objective: Ectopic atrial tachycardia (EAT) is a common type of supraventricular tachycardia in pediatric population, and it can be resistant to antiarrhythmic drugs and lead to tachycardia induced cardiomyopathy (TIC) if not properly managed. This study assessed the clinical course and response to treatment of EAT in children.

    Method: A retrospective review included 144 children at the First Hospital of Tsinghua University diagnosed with EAT from January 2009 to April 2014. Read More

    Incidence, Clinical Course, and Risk Factors of Amiodarone-Induced Thyroid Dysfunction in Japanese Adults With Congenital Heart Disease.
    Circ J 2015 27;79(8):1828-34. Epub 2015 May 27.
    Department of Pediatric Cardiology, Tokyo Women's Medical University.
    Background: Although amiodarone (AMD)-induced thyroid dysfunction (AITD) is an important complication of AMD therapy, little is known about AITD in adult Japanese patients with congenital heart disease (CHD).

    Methods And Results: We retrospectively studied 131 adult patients with CHD who were on low-dose AMD (median, 150 mg/day). The median patient age was 28 years, and the median follow-up was 44 months. Read More

    Amiodarone and the thyroid.
    Endokrynol Pol 2015 ;66(2):176-86
    Department of Endocrinology, Jagiellonian University, Medical College, Krakow, Poland.
    Amiodarone, a benzofuranic iodine-rich antiarrhythmic drug, causes thyroid dysfunction in 15-20% of cases. Amiodarone can cause both hypothyroidism (AIH, amiodarone-induced hypothyroidism) and thyrotoxicosis (AIT, amiodarone-induced thyrotoxicosis). AIH is treated by L-thyroxin replacement and does not need amiodarone discontinuation. Read More

    Therapeutic particularities in amiodarone induced thyroid disorder in patients with underlying cardiac condition.
    Rev Med Chir Soc Med Nat Iasi 2014 Oct-Dec;118(4):959-64
    University of Medicine and Pharmacy Grigore T. Popa - Iaşi, Department of Medical Specialties (I).
    Aim: the analysis of therapeutic approach in patients with basic heart condition and amiodarone induced thyroid dysfunction--correlations with the evolution and prognosis.

    Material And Methods: The study included 215 patients, 90 men and 125 women aged between 35 and 87, with different cardiac pathologies hospitalized in the Cardiology Clinic between 2004-2014, who received amiodarone treatment, in most cases for prophylaxis of various arrhythmias, both supraventricular and ventricular. During the evolution, these patients have developed amiodarone-induced thyroid dysfunction (hypo- or hyper function). Read More

    [Non-autoimmune thyroiditis].
    Medicina (B Aires) 2014 ;74(6):481-92
    Dirección Médica Química Montpellier SA, Buenos Aires, Argentina. E-mail:
    The term thyroiditis comprises a group of thyroid diseases characterized by the presence of inflammation, including autoimmune and non-autoimmune entities. It may manifest as an acute illness with severe thyroid pain (subacute thyroiditis and infectious thyroiditis), and conditions in which the inflammation is not clinically evident evolving without pain and presenting primarily thyroid dysfunction and/or goiter (drug-induced thyroiditis and Riedel thyroiditis). The aim of this review is to provide an updated approach on non-autoimmune thyroiditis and its clinical, diagnostic and therapeutic aspects. Read More

    Amiodarone-induced thyrotoxicosis: type 1 or type 2?
    BMJ Case Rep 2014 Oct 27;2014. Epub 2014 Oct 27.
    Walsall Hospitals Healthcare NHS Trust, Walsall, UK.
    A 69-year-old man presented with a 6-week history of shortness of breath on exertion, unintentional weight loss, altered bowel habits and lethargy. He was diagnosed with atrial fibrillation 2 years previously and started on amiodarone and warfarin. He subsequently reverted to sinus rhythm and his medication was stopped 1 year prior to presentation. Read More

    Amiodarone-induced thyroid dysfunction--clinical picture. Study on 215 cases.
    Rev Med Chir Soc Med Nat Iasi 2014 Apr-Jun;118(2):359-63
    Aim: The purpose of this study was to investigate the prevalence and the clinical-evolutionary implications of thyroid damage in patients treated with amiodarone in the Cardiology Clinic of the "Sf. Spiridon" University Hospital of Iasi.

    Material And Methods: The study included a group of 215 patients, 90 men and 125 women with ages between 35 and 87, hospitalized in the Cardiology Clinic between 2004 and 2014, who received amiodarone treatment, in most cases for the prophylaxis of various arrhythmias, both supra-ventricular and ventricular. Read More

    Relation between Endogenous Stem Cells and Green Tea Extract in Overconsumption and Amiodarone Induced Thyroid Damage in Rat.
    Int J Stem Cells 2013 Nov;6(2):113-20
    Department of Histology, Faculty of Medicine, Beni-Suef University, Cairo, Egypt.
    Background And Objectives: Amiodarone (AM), one of the most commonly prescribed antiarrhythmics, is frequently associated with thyroid dysfunction. Green tea extract (GTE) supplementation would attenuate oxidative stress and activate progenitor cells. However, the potential toxicity of GTE on various organs when administered at high doses has not been completely investigated. Read More

    Incidence and pattern of thyroid dysfunction in patients on chronic amiodarone therapy: experience at a tertiary care centre in oman.
    Open Cardiovasc Med J 2013 29;7:122-6. Epub 2013 Nov 29.
    Department of Pharmacology & Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman ; Gulf Health Research, Muscat, Oman.
    Objective: To determine the incidence and pattern of thyroid dysfunction (TD) in patients on chronic amiodarone therapy.

    Methods: A retrospective study which evaluated 59 patients who had received amiodarone therapy regularly for at least 12 months from a period of 3 years from October 2007 to October 2010. The patients were followed-up at the cardiac clinic at Sultan Qaboos University Hospital, Muscat, Oman. Read More

    Clinical and therapeutic aspects of amiodarone induced thyroid dysfunction.
    Rev Med Chir Soc Med Nat Iasi 2013 Apr-Jun;117(2):375-9
    Department of Cardiology, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa" - Iasi.
    Discovered in 1961 by Tondeur and Binon, two Belgian chemists, amiodarone was widely used, especially in Europe, initially as an antianginal agent, and later as an antiarrhythmic one (following the experiments conducted at the University of Oxford by Dr. Bramah Singh). Thus, the role of amiodarone was reconsidered, becoming, together with Sotalol, a class III antiarrhythmic--a group characterized by the action of extending the potassium channels refractory period. Read More

    Hypothyroidism and reversible kidney dysfunction: an essential relationship to recognize.
    Endocr Pract 2014 May;20(5):490-9
    Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
    Objective: To report 3 cases of reversible hypothyroidism-induced kidney dysfunction and review the interaction between these commonly encountered, yet seemingly disparate, conditions.

    Methods: We describe the clinical course and laboratory and physical findings of 3 patients who presented with kidney dysfunction that improved after initiating thyroid hormone replacement therapy. We also review similar cases in the literature and discuss the pathophysiologic mechanisms. Read More

    Preoperative therapeutic apheresis for severe medically refractory amiodarone-induced thyrotoxicosis: a case report.
    J Clin Apher 2014 Jun 22;29(3):168-70. Epub 2013 Nov 22.
    Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
    Introduction: Amiodarone is associated with thyroid dysfunction and life-threatening thyrotoxicosis. In medically refractory cases, or where medical therapy is contraindicated, thyroidectomy may be required. To decrease perioperative thyroid storm and to reduce overall surgical risk, apheresis may be considered preoperatively to restore euthyroidism. Read More

    Amiodarone-induced thyroid dysfunction.
    J Intensive Care Med 2015 May 24;30(4):179-85. Epub 2013 Sep 24.
    Department of Medicine, NYU School of Medicine, New York, NY, USA.
    Amiodarone is an effective medication for the treatment of cardiac arrhythmias. Originally developed for the treatment of angina, it is now the most frequently prescribed antiarrhythmia drug despite the fact that its use is limited because of potential serious side effects including adverse effects on the thyroid gland and thyroid hormones. Although the mechanisms of action of amiodarone on the thyroid gland and thyroid hormone metabolism are poorly understood, the structural similarity of amiodarone to thyroid hormones, including the presence of iodine moieties on the inner benzene ring, may play a role in causing thyroid dysfunction. Read More

    [Amiodarone treatment and thyroid disorders].
    Pol Merkur Lekarski 2013 Jul;35(205):5-9
    Uniwersytet Medyczny im. Katedra Endokrynologii, Przemiany Materii i Chorób Wewnetrznych.
    Amiodarone is a benzofuranic iodine-rich antiarrhythmic drug used in the treatment of severe tachyarrhythmias, especially ventricular. Drug causes many adverse effects including thyroid disorders in 14-18% of patients: amiodarone induced thyrotoxicosis type I and type II (AIT I, AIT II) and amiodarone induced hypothyroidism (AIH). AIT occurs more frequently in geographical areas with low iodine intake, whereas AIH is more frequent in iodine-sufficient areas. Read More

    [A case of simultaneously occurred amiodarone-induced hepatitis and hypothyroidism].
    Korean J Gastroenterol 2013 Jul;62(1):59-63
    Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea.
    Amiodarone is a di-iodated benzofuran derivative that is commonly used to treat patients with various cardiac arrhythmias. It is associated with side effects that involve the liver, thyroid, and other organs. Approximately 1-3% of patients treated with amiodarone suffer from symptomatic liver disease. Read More

    Atrial fibrillation in the elderly.
    Drugs Aging 2013 Aug;30(8):593-601
    Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
    Atrial fibrillation (AF) is the most common arrhythmia in older adults with a prevalence of 9 % in adults aged 80 years or older. AF patients have a five times greater risk of developing stroke than the general population. Using anticoagulants for stroke prevention in the elderly becomes a challenge because both stroke and bleeding complications increase with age. Read More

    Catheter ablation of paroxysmal atrial fibrillation in patients with previous amiodarone-induced hyperthyroidism: a case-control study.
    J Cardiovasc Electrophysiol 2013 Aug 9;24(8):888-93. Epub 2013 Apr 9.
    Department of Electrophysiology, Almazov Federal Heart, Blood and Endocrinology Centre, Saint-Petersburg, Russian Federation.
    Introduction: Many patients with atrial fibrillation (AF) receive amiodarone. Amiodarone-induced hyperthyroidism (AIH) may develop as a complication. We hypothesized that pulmonary vein (PV) isolation in patients with paroxysmal AF and history of AIH may yield a lower success rate. Read More

    Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice.
    Mol Cell Biochem 2013 Jul 27;379(1-2):97-105. Epub 2013 Mar 27.
    Department of Pharmacology, University of Athens, Athens, Greece.
    Thyroid hormone receptor α1 (TRα1) is shown to be critical for the maturation of cardiomyocytes and for the cellular response to stress. TRα1 is altered during post ischemic cardiac remodeling but the physiological significance of this response is not fully understood. Thus, the present study explored the potential consequences of selective pharmacological inhibition of TRα1 on the mechanical performance of the post-infarcted heart. Read More

    Thyrotoxicosis-facilitated bridge to recovery with a continuous-flow left ventricular assist device.
    Eur J Cardiothorac Surg 2013 Sep 1;44(3):573-4. Epub 2013 Mar 1.
    Department of Cardiopulmonary Transplantation, Texas Heart Institute at St Luke's Episcopal Hospital, Houston, TX 77225-0345, USA.
    The HeartMate II is a continuous-flow left ventricular assist device that can be explanted from patients after cardiac recovery. We implanted a HeartMate II in a 21-year-old man who had idiopathic cardiomyopathy. A year later, he developed thyrotoxicosis, presumably secondary to amiodarone administered for ventricular fibrillation. Read More

    [Thyroid dysfunction and amiodarone].
    Arq Bras Endocrinol Metabol 2013 Feb;57(1):71-8
    Serviço de Medicina Interna dos Hospitais de Universidade de Coimbra, Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal.
    Although most patients remain clinically euthyroid, some develop amiodarone-induced hyperthyroidism (HPEAI) or hypothyroidism (HPOAI). The authors present a retrospective analysis of ten patients with amiodarone-induced thyroid dysfunction. Six patients were female and mean amiodarone intake was 17. Read More

    [Amiodarone and thyroid].
    Rev Med Suisse 2012 Nov;8(362):2175-6, 2178-80
    Service de médecine interne générale, HUG, 1211 Geneve 14.
    Amiodarone, an iodine-rich drug, results in mild disturbances of thyroid function in most patients and in thyroid dysfunction in approximately 20% of them. Hypothyroidism, mainly found in countries without iodine deficiency, is substituted with levothyroxine and does not need amiodarone to be discontinued. Hyperthyroidism, commonly found in areas of iodine deficiency, is more complex and usually motivates discontinuation of amiodarone. Read More

    [Drug-induced thyroid dysfunction].
    Nihon Rinsho 2012 Nov;70(11):1958-64
    Internal Medicine II, Kansai Medical University.
    Various drugs may cause thyroid dysfunction. The drugs which may cause thyrotoxicosis include interferon, molecular-targeted agents, amiodarone, thyroid hormone itself and so on. Those which cause hypothyroidism include anti-thyroid drugs, lithium and iodine etc. Read More

    Mechanisms in endocrinology: Heart failure and thyroid dysfunction.
    Eur J Endocrinol 2012 Nov 6;167(5):609-18. Epub 2012 Sep 6.
    Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Italy.
    Context: Heart failure (HF) is a major cause of morbidity and mortality in Europe and in the United States. The aim of this review article was to assess the results of the prospective studies that evaluated the risk of HF in patients with overt and subclinical thyroid disease and discuss the mechanism of this dysfunction.

    Evidence Acquisition: Reports published with the following search terms were searched:, thyroid, hypothyroidism, hyperthyroidism, subclinical hyperthyroidism, subclinical hypothyroidism, levothyroxine, triiodothyronine, antithyroid drugs, radioiodine, deiodinases, clinical symptoms, heart rate, HF, systolic function, diastolic function, systemic vascular resistance, endothelial function, amiodarone and atrial fibrillation. Read More

    Amiodarone therapy: don't forget thyroid.
    J Pak Med Assoc 2012 Mar;62(3):268-72
    Department of Radiology, The Agha Khan University Hospital (AKUH), Karachi Institute of Radiotherapy And Nuclear Medicine (KIRAN), Karachi, Pakistan.
    Amiodarone is an effective anti-arrhythmic agent for control of various life threatening ventricular tachyarrhythmias but may give Various side effects. Clinically relevant thyroid dysfunction is not uncommon during amiodarone therapy and is caused by iodide excess and inhibition of deiodinase activity. Amiodarone induced thyroid dysfunction varies from asymptomatic variation in thyroid function to clinically overt hypothyroidism and thyrotoxicosis. Read More

    Amiodarone and the thyroid: a 2012 update.
    J Endocrinol Invest 2012 Mar 19;35(3):340-8. Epub 2012 Mar 19.
    Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy.
    Amiodarone-induced thyroid dysfunction occurs in 15-20% of amiodarone-treated patients. Amiodarone-induced hypothyroidism (AIH) does not pose relevant problems, is easily controlled by L-thyroxine replacement, and does not require amiodarone withdrawal. Most frequently AIH develops in patients with chronic autoimmune thyroiditis. Read More

    Thyrotoxicosis.
    Lancet 2012 Mar 5;379(9821):1155-66. Epub 2012 Mar 5.
    Centre for Diabetes, Endocrinology and Metabolism, School of Clinical and Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
    Thyrotoxicosis is a common disorder, especially in women. The most frequent cause is Graves' disease (autoimmune hyperthyroidism). Other important causes include toxic nodular hyperthyroidism, due to the presence of one or more autonomously functioning thyroid nodules, and thyroiditis caused by inflammation, which results in release of stored hormones. Read More

    Therapy-resistant ventricular tachycardia caused by amiodarone-induced thyrotoxicosis: a case report of electrical storm.
    Am J Emerg Med 2012 Nov 3;30(9):2092.e5-7. Epub 2012 Mar 3.
    Department of Cardiology, Meram School of Medicine, Cardiology Department, Konya 42090, Turkey.
    Electrical storm is a challenging diagnosis for the clinician and requires detailed evaluation of the patient. Amiodarone is frequently used for the cessation of ventricular tachycardia attacks. Within antiarrhythmic effects of amiodarone, there are some harmful effects of the recent drug. Read More

    [Amiodarone and thyroid dysfunction].
    Medicina (B Aires) 2012 ;72(1):63-74
    Estudios Metabólicos y Endocrinos, Buenos Aires.
    Amiodarone is a structural analogue of thyroid hormone, and some of its anti-arrhythmic actions and toxicity are attributable to its interaction with nuclear receptors of thyroid hormones. Being highly lipophilic, amiodarone is concentrated in many tissues and is eliminated, consequently, very slowly. It is preferably employed to manage life-threatening arrhythmias, including ventricular fibrillation and unstable ventricular tachycardia. Read More

    Amiodarone-induced thyroid dysfunction: brand-name versus generic formulations.
    CMAJ 2011 Sep 11;183(12):E817-23. Epub 2011 Jul 11.
    Division of Internal Medicine, McGill University Health Center, Montréal, Que.
    Background: Amiodarone is associated with dysfunction of the thyroid. Concerns have arisen regarding the potential for adverse effects with generic formulations of amiodarone. We evaluated and compared the risk of thyroid dysfunction between patients using brand-name versus generic formulations of amiodarone and identified risk factors for thyroid dysfunction. Read More

    Determinants and outcome of amiodarone-associated thyroid dysfunction.
    Clin Endocrinol (Oxf) 2011 Sep;75(3):388-94
    Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
    Objective: Amiodarone is frequently associated with thyroid dysfunction. Identifying predictors for amiodarone-associated thyroid dysfunction and assessing treatment outcome may aid clinicians in daily practice.

    Methods: We included 303 consecutive patients with amiodarone therapy for cardiac arrhythmias (260 with atrial fibrillation and 43 with ventricular arrhythmias). Read More

    Amiodarone-induced hypothyroidism and other adverse effects.
    Dimens Crit Care Nurs 2011 Mar-Apr;30(2):87-93
    Southwest General Health Center in Middleburg Heights, Ohio, USA.
    Amiodarone is a class III antiarrhythmic agent that is frequently prescribed today for the treatment of ventricular and atrial arrhythmias. Amiodarone has many adverse effects, and one of them is thyroid dysfunction. Advanced practice and staff nurses need to be vigilant, recognizing early signs and symptoms of thyroid dysfunction to prevent adverse drug reactions. Read More

    Amiodarone and thyrotoxicosis: case reports.
    Arq Bras Cardiol 2010 Oct;95(5):e122-4
    Hospital Universitário Clementino Fraga Filho, UFRJ, Rio de Janeiro, RJ, Brasil.
    Amiodarone-induced thyroid dysfunction has been reported to affect 2-24% of users. Despite the easy management of amiodarone-induced hypothyroidism, the development of thyrotoxicosis leads to a difficult approach in most cases. The aim of this study is to describe three different cases of patients with amiodarone-induced thyrotoxicosis and discuss the clinical and laboratorial aspects, and the different approaches to them. Read More

    Amiodarone-induced thyroid dysfunction in the Hong Kong Chinese population.
    Hong Kong Med J 2010 Dec;16(6):434-9
    Department of Medicine and Geriatrics, Kwong Wah Hospital, 25 Waterloo Road, Hong Kong.
    Objective: To determine the frequency, risk factors, clinical features, and management of amiodarone-induced thyroid dysfunctions.

    Design: Retrospective study.

    Setting: A regional hospital in Hong Kong. Read More

    Approach to the patient with amiodarone-induced thyrotoxicosis.
    J Clin Endocrinol Metab 2010 Jun;95(6):2529-35
    Department of Endocrinology, University of Pisa, Ospedale Cisanello, Via Paradisa, 2, 56124 Pisa, Italy.
    Amiodarone, a benzofuranic iodine-rich antiarrhythmic drug, causes thyroid dysfunction in 15-20% of cases. Although amiodarone-induced hypothyroidism poses no particular problem, amiodarone-induced thyrotoxicosis (AIT) is a diagnostic and therapeutic challenge. There are two main forms of AIT: type 1, a form of iodine-induced hyperthyroidism, and type 2, a drug-induced destructive thyroiditis. Read More

    Drug-induced endocrine disorders in the intensive care unit.
    Crit Care Med 2010 Jun;38(6 Suppl):S219-30
    Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy-Rutgers, State University of New Jersey, New Brunswick, NJ, USA.
    The neuroendocrine response to critical illness is key to the maintenance of homeostasis. Many of the drugs administered routinely in the intensive care unit significantly impact the neuroendocrine system. These agents can disrupt the hypothalamic-pituitary-adrenal axis, cause thyroid abnormalities, and result in dysglycemia. Read More

    [Amiodarone-induced thyroid gland dysfunctions].
    Dtsch Med Wochenschr 2010 Apr 13;135(16):807-11. Epub 2010 Apr 13.
    Klinik III für Innere Medizin, Herzzentrum der Universität zu Köln.
    Amiodarone treatment affects thyroid status in about the half of patients. Amiodarone causes a wide spectrum of effects on the thyroid function including hypothyroidism and thyreotoxicosis. Amiodaron-induced thyroid dysfunction is the most reason for discontinuation of amiodaron therapy. Read More

    1 OF 4